X

Vous n'êtes pas connecté

  - ONCOLOGYNEWS.COM.AU - A La Une - 30/Jun 18:31

IGF2BP1: a critical driver of cancer progression and therapeutic target

The RNA-binding protein IGF2BP1 has emerged as a key regulator of cancer hallmarks, influencing tumour proliferation, metastasis, immune evasion, and resistance to cell death. As an m6A reader, IGF2BP1 binds to methylated mRNA, stabilising oncogenic transcripts and promoting cancer progression. Its role in regulating gene expression at the post-transcriptional level has positioned IGF2BP1 as a [...]

Articles similaires

IGF2BP1: a critical driver of cancer progression and therapeutic target

oncologynews.com.au - 30/Jun 18:31

The RNA-binding protein IGF2BP1 has emerged as a key regulator of cancer hallmarks, influencing tumour proliferation, metastasis, immune evasion, and...

Targeting mitochondrial dynamics to combat breast cancer metastasis

news.medical.net - 28/Jun 01:31

Breast cancer, particularly triple-negative breast cancer (TNBC), remains a leading cause of cancer-related mortality due to its aggressive nature and...

Researchers uncover how RNA modifications evade immune detection

news.medical.net - 01/Jul 16:47

The innate immune system is the body's first line of defense against pathogens and foreign substances. An essential component of this system are...

The role of fusion genes in cancer development and treatment

oncologynews.com.au - 30/Jun 12:22

Fusion genes, arising from abnormal chromosomal rearrangements, are gaining recognition as pivotal players in cancer development. These genetic...

Inflammatory Mediators: Key Players in Postmenopausal Breast Cancer

medindia.net - 23/Jun 07:09

Inflammatory mediators like cytokines and chemokines play a key role in driving age-related and postmenopausal breast cancer progression and immune...

Study provides new insights into the genetic complexity of cancer metastasis

oncologynews.com.au - 30/Jun 12:20

When cancer spreads from a primary tumour to new sites throughout the body, it undergoes changes that increase its genetic complexity. A new study...

FAM111B identified as a key driver of glioma progression and therapeutic target

news.medical.net - 28/Jun 00:13

Gliomas are among the deadliest brain tumors, with limited treatment options and poor survival rates. Scientists from China identified FAM111B, a...

Could AI Understand Your Tumour Better Than a Doctor?

medindia.net - 26/Jun 14:46

What if we told you that not all cancer cells in a tumour are the same-and that's exactly why some treatments fail? A groundbreaking AI tool called...

Could AI Understand Your Tumour Better Than a Doctor?

medindia.net - 27/Jun 02:10

New AI tool, maps cancer cell diversity into five key types, unlocking the potential for personalized treatment and improved outcomes in breast...

Researchers uncover surprising role of ‘natural killer’ cells in resistance to cancer immunotherapy

oncologynews.com.au - 30/Jun 18:35

Melanoma, one of the deadliest forms of skin cancer, affects an estimated 330,000 people worldwide each year and causes nearly 60,000 deaths...

Les derniers communiqués

  • Aucun élément